Search results
Bristol Myers (BMY) Loses 20.5% YTD: Should You Retain or Fold?
Zacks via Yahoo News· 2 days agoThe acquisition of Karuna Therapeutics added KarXT (xanomeline-trospium) to its pipeline. The...
SpringWorks (SWTX) Rises More Than 40% in a Year: Here's Why
Zacks via Yahoo News· 2 days agoSpringWorks' (SWTX) Ogsiveo is the first drug approved by the FDA to treat desmoid tumors. The...
Kazia Therapeutics (KZIA) Soars 490% in a Week: Here's Why
Zacks via Yahoo News· 2 days agoKazia (KZIA) surges after positive data from a phase II/III study on its lead pipeline drug in...
Verona (VRNA) Stock Surges 36% in the Past Month: Here's Why
Zacks via Yahoo News· 2 days agoVerona Pharma (VRNA) surges on the recent FDA approval for its lead drug, which is the first inhaled...
Zacks Initiates Coverage of Comstock With Neutral Recommendation
Zacks via Yahoo News· 2 days agoDiscover why Zacks rates Comstock as "Neutral," being the first on Wall Street to initiate coverage...
Fewer home sales and lower average housing prices in Canada compared to last year
CBC via Yahoo News· 2 days agoReal estate activity across Canada in June showed a drop in both sales and housing prices compared...
Pfizer (PFE) Moves Forward With Once-Daily Obesity Pill Study
Zacks via Yahoo News· 2 days agoPreviously, Pfizer faced setbacks related to its pipeline candidates for obesity. In December last...
The Zacks Analyst Blog Highlights Danaher, Morgan Stanley, Pfizer, Elite Pharmaceuticals and Oil-Dri
Zacks via Yahoo News· 2 days agoRising costs are also likely to hurt its profitability. However, resurgence of its investment...
Pharma Stock Roundup: LLY to Buy Morphic, PFE Advances Obesity Drug Development
Zacks via Yahoo News· 2 days agoEli Lilly (LLY) offers to acquire Morphic Therapeutics for $3.2 billion. Pfizer (PFE) selects a...
Silence Therapeutics (SLN) Moves 5.8% Higher: Will This Strength Last?
Zacks via Yahoo News· 2 days agoSilence Therapeutics (SLN) witnessed a jump in share price last session on above-average trading...